Future Fields secures $8M in Series A funding led by Amplify Capital, BDC Climate Tech Fund, and R7 Partners to enhance biomanufacturing capabilities for innovative medicines.
Future Fields secures $8M in Series A funding led by Amplify Capital, BDC Climate Tech Fund, and R7 Partners to enhance biomanufacturing capabilities for innovative medicines.
06/17/25, 2:16 PM
Location
edmontonMoney raised
$8 million
Industry
biotechnology
Round Type
series a
Investors
R7 Partners, Business Development Bank Of Canada (Bdc) Climate Tech Fund, Amplify Capital
Future Fields has successfully closed an oversubscribed $8 million Series A funding round. The investment will support the company's growth in producing critical proteins for agriculture, food, and biopharma sectors. Led by notable investors, this funding showcases strong interest in their sustainable biomanufacturing technology. Future Fields aims to expand its operational capacity to meet the increasing demands in the synthetic biology industry.
Company Info
Location
edmonton, alberta, canada
Additional Info
Future Fields is a fly biotechnology company based in Edmonton, Canada. Founded in 2018, Future Fields is on a mission to change how we do science for humanity and the planet. Our biomanufacturing platform, the EntoEngine™, is the first synthetic biology system in the world to use fruit flies for recombinant protein production. Powered by people and fly by design, we’re equipping industries with the biomolecular tools they need to sustainably, ethically, and economically conduct great science.